Earnings Date
Nov 14
EPS
$-0.370
Quarterly Revenue
$0K
Annual Revenue (as of Sep 30)
$55.2K
Earnings History
Analyze the earnings history of Gain Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/14/2023 | AM | GANX | Q3 | -$0.38 | -$0.45 | -$0.37 | 17.78% | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2023 | AM | GANX | Q2 | -$0.43 | -$0.31 | -$0.62 | -100.00% | $95.10K | $1.01M | $0.00 | -100.00% | Get Alert |
| 05/12/2023 | AM | GANX | Q1 | -$0.28 | — | -$0.43 | — | $45.00K | — | $55.18K | — | Get Alert |
| 03/23/2023 | PM | GANX | Q4 | -$0.26 | -$0.38 | -$0.39 | -2.63% | $43.21K | $10.00K | $0.00 | -100.00% | Get Alert |
| 11/10/2022 | PM | GANX | Q3 | -$0.39 | -$0.46 | -$0.38 | 17.39% | $27.34M | $60.00K | $0.00 | -100.00% | Get Alert |
| 08/08/2022 | AM | GANX | Q2 | -$0.30 | -$0.31 | -$0.43 | -38.71% | $89.71M | $30.00K | $95.10K | 217.01% | Get Alert |
| 05/16/2022 | PM | GANX | Q1 | -$0.50 | -$0.37 | -$0.28 | 24.32% | $5.27K | $40.00K | $45.00K | 12.50% | Get Alert |
| 03/24/2022 | AM | GANX | Q4 | -$0.53 | -$0.49 | -$0.26 | 46.94% | $9.14K | $50.00K | $43.21K | -13.58% | Get Alert |
| 11/12/2021 | AM | GANX | Q3 | -$0.25 | -$0.36 | -$0.39 | -8.33% | $6.70K | $10.00K | $27.34K | 173.45% | Get Alert |
| 08/11/2021 | AM | GANX | Q2 | -$0.27 | -$0.30 | -$0.30 | 0.00% | — | — | $89.71K | — | Get Alert |
| 05/10/2021 | PM | GANX | Q1 | -$0.29 | -$0.19 | -$0.50 | -163.16% | $6.67M | — | $5.27K | — | Get Alert |
When is Gain Therapeutics (NASDAQ:GANX) reporting earnings?
Gain Therapeutics (GANX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3.
What were the latest earnings per share (EPS) for Gain Therapeutics (NASDAQ:GANX)?
Gain Therapeutics (GANX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual EPS was $-0.37, which beat the estimate of $-0.45.
What were Gain Therapeutics’s (NASDAQ:GANX) revenues?
Gain Therapeutics (GANX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.